Kala Pharmaceuticals' IPO

Kala Pharmaceuticals raised a round of funding on July 20, 2017. Investors include Public.

Kala Pharmaceuticals (NASDAQ: KALA) is developing medicines that have the ability to rapidly and effectively penetrate mucosal barriers resulting in therapeutic efficacy and transformative treatment o…

Articles about Kala Pharmaceuticals' IPO: